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BioenergeticsNeurodegenerative and neurological disorders are often characterised by pathological changes to dendrites, in
advance of neuronal death. Oxidative stress, energy deﬁcits and excitotoxicity are implicated in many such
disorders, suggesting a potential vulnerability of dendrites to these situations. Here we have studied dendritic
vs. somatic responses of primary cortical neurons to these types of challenges in real-time.
Using a genetically encoded indicator of intracellular redox potential (Grx1-roGFP2) we found that, compared to
the soma, dendritic regions exhibitedmore dramaticﬂuctuations in redox potential in response to sub-lethal ROS
exposure, and existed in a basally more oxidised state. We also studied the responses of dendritic and somatic
regions to excitotoxic NMDA receptor activity. Both dendritic and somatic regions experienced similar increases
in cytoplasmic Ca2+. Interestingly, while mitochondrial Ca2+ uptake and initial mitochondrial depolarisation
were similar in both regions, secondary delayed mitochondrial depolarisation was far weaker in dendrites, po-
tentially as a result of less NADH depletion. Despite this, ATP levels were found to fall faster in dendritic regions.
Finally we studied the responses of dendritic and somatic regions to energetically demanding action potential
burst activity. Burst activity triggered PDH dephosphorylation, increases in oxygen consumption and cellular
NADH:NAD ratio. Compared to somatic regions, dendritic regions exhibited a smaller degree of mitochondrial
Ca2+ uptake, lower fold-induction of NADH and larger reduction in ATP levels. Collectively, these data reveal
that dendritic regions of primary neurons are vulnerable to greater energetic and redox ﬂuctuations than the
cell body, which may contribute to disease-associated dendritic damage. This article is part of a Special Issue en-
titled: 13th European Symposium on Calcium.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
In many chronic and acute conditions of the brain involving neuro-
nal dysfunction there is substantial evidence that the effects of a diverse
array of disease-causing events, agents and mutations at least partly
converge on a common set of consequences centred on excitotoxicity,
energy imbalance, oxidative stress and mitochondrial dysfunction [55,
70,71,74,91].
Excitotoxicity is caused by the global or local accumulation of
glutamate, leading to inappropriate activity of the NMDA subtype of
glutamate receptor (NMDAR) which mediates Ca2+-dependent cell
death and dysfunction [17,61]. This ‘excitotoxicity’ is a major contribu-
tor to neuronal loss and dysfunction in acute neurological disorders
including stroke and traumatic brain injury [60]. However, more local,
progressive excitotoxicity is also implicated in the pathogenesis of
neurodegenerative disease [62,80]. For example, synaptic loss inopean Symposium on Calcium.
ingham).
. This is an open access article underAlzheimer's disease (AD) models induced by oligomeric Aβ is thought
to proceed at least in part via a local NMDAR-dependent excitotoxic
mechanism [53,66]. Huntington's disease is also a disorder associated
with aberrant NMDAR activity and excitotoxicity [29], in part due to
an elevation of extrasynaptic NMDAR activity which promotes neuronal
dysfunction as well as preventing non-toxic mHtt inclusion formation
[72,77].
The principle cause of excitotoxicity in stroke is a loss of bioenergetic
homeostasis, leading to dysfunctional glutamate uptake mechanisms
and accumulation of extracellular glutamate. Furthermore there is con-
siderable evidence that energetic and metabolic perturbations occur in
chronic neurodegenerative diseases, not just acute disorders such as
stroke or traumatic brain injury [58]. Central to energy homeostasis, of
course, is the requirement that functional mitochondria are able to re-
spond to the changing demands of a neuron (for example during
periods of strong synaptic activity). Dysfunctional mitochondria are a
hall-mark of many chronic and acute neurological disorders, which
can be triggered by both excitotoxic and non-excitotoxic mechanisms.
An example of the latter is oxidative stress, which is not only triggered
by excitotoxicity and a variety of disease-causing agents andmutations,
but can also be further exacerbated by mitochondrial dysfunction.the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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and biochemically distinct regions, it is perhaps not surprising that
these regions are differentially affected under pathological conditions.
For example, there is good evidence that changes in dendritic and
axonalmorphology and properties take place in neurodegenerative dis-
ease in advance of neuronal loss [65]. In AD and mouse models of AD,
dystrophic neurites and spine alterations correlate with proximity to
amyloid plaques [35,87]. Moreover, in animalmodels of AD dendritic al-
terations have been observed in advance of plaque formation [84] and
recent evidence suggests that structural dendritic deﬁcits in an AD
model are functionally linked to hyperexcitability [85]. α-Synuclein in-
clusions promote mitochondrial oxidative stress in dopaminergic neu-
rons that is higher in dendritic regions than in the soma, suggestive of
dendritic vulnerability in Parkinson's disease [25]. Even normal ageing
is associated with a reduction in dendritic complexity and spine num-
bers [23]. Acute excitotoxicity such as exposure to NMDA or oxygen–
glucose deprivation also triggers early dendritic alterations in the form
of neuritic beads [36], although their role (protective or pathological)
is not well understood.
Despite this, we have an incomplete picture of how dendritic vs.
somatic regions respond in real-time to metabolic, oxidative and
excitotoxic stress. This knowledge could help understand the types of
insult that trigger selective vulnerability to more peripheral regions of
a neuron, as well as indicate whether classical neuroprotective strate-
gies are appropriate for preventingmore localised dendritic or synaptic
damage. Key to gaining a better understanding of real-time responses of
neurons to various forms of stress has been the development of an
expanding array of genetically encoded indicators designed to report
on a variety of metabolic intermediates, second messenger levels, and
signal pathway activity. Particularly important for studying dynamic
neuronal responses to excitotoxic, metabolic and oxidative stress in-
clude mitochondrially targeted Ca2+ indicators, probes for NADH:NAD
ratio, ATP levels, AMPK activity and cellular redox state (GSH:GSSG
ratio). These indicators can be usefully employed in parallel with more
classical imaging techniques, such as charged dye reporting of
mitochondrial membrane potential, and NAD(P)H autoﬂuorescence
measurements.
Herewe have employed these existing probes, plus a newly targeted
version of GCaMP2, to compare dendritic vs. somatic responses of corti-
cal neurons to excitotoxic insults (lethal and sub-lethal), a sub-lethal
oxidative challenge, and ﬁnally the metabolic demands of intense syn-
aptic activity. As well as illustrating the utility of these probes, we
found that compared to the soma, dendrites were more susceptible to
strong ﬂuctuations in redox state and ATP levels. However, dendritic
mitochondria appeared more resistant to catastrophic depolarisation
during exposure to excitotoxic insults.
2. Results
2.1. Analysis of subcellular redox potential changes following H2O2
exposure
We ﬁrst decided to compare dendritic vs. somatic responses to an
oxidative challenge. Classical probes are based on non-ﬂuorescent
dyes which, upon oxidation, become ﬂuorescent. However, this is a
one-way reaction and so does not indicate recovery of redox status. To
visualise the redox potential of the cell directly, we transfected neurons
with a vector encoding theGrx1-roGFP2 genetically encoded reporter of
the glutathione redox potential [42] (Fig. 1A). The 390/480 nm excita-
tion ratio of Grx1-roGFP2 is highly sensitive to small ﬂuctuations in
redox potential. Its dynamic range (−320 to −240 mV [42]) means
that small changes in the degree of GSH oxidation lead to large changes
in Grx1-roGFP2 signal [42] and so it is ideal for measuring cellular
responses to sub-toxic oxidative challenges. We found that low doses
of H2O2 produced strong ﬂuctuations in the probe signal which were
frequently saturated at above 25 μM H2O2. Using a H2O2 dose wellwithin the dynamic range (10 μM H2O2) we monitored the ﬂuctuation
in glutathione redox potential in somatic vs. dendritic regions, normal-
ised to the maximal response elicited by a high dose of H2O2 (100 μM).
We found that dendritic regions exhibited stronger perturbations to the
glutathione redox potential, compared to the soma of that same cell.
Fig. 1B shows an example recording from the dendritic and somatic
regions of a single cell, and Fig. 1C shows the full data set, and Fig. 1E
shows the 10 μM H2O2-induced change in both regions. We also ob-
served that dendritic Grx1-roGFP2 ratios tended to be higher in dendrit-
ic regions compared to their soma, suggesting an elevated basal
oxidation state. To test this, in a set of cells we treated them with DTT
to provide highly reducing conditions in order to minimize the 390/
480 nm excitation ratio. We found that the effect of DTT was greater
in dendritic regions than in somatic regions, suggesting that dendrites
are indeed in an elevated basal oxidation state.
2.2. Analysis of subcellular metabolic and mitochondrial changes during
excitotoxicity
Wenext investigated somatic and dendritic responses to excitotoxic
Ca2+ inﬂux through the NMDA receptor (NMDAR). We ﬁrst studied the
consequences of excitotoxic NMDAR activity for cellular ATP levels in
dendritic and somatic regions. We used the genetically encoded ATP
FRET probe AT1.03 [52], which shows a YFP/CFP emission ratio of
around 1.6 in resting neurons, and which falls to around 0.6 upon
depletion of cellular ATP achieved by treatment with the mitochondrial
uncoupler FCCP (data not shown). Application of NMDA (100 μM) elic-
ited similar increases in cytoplasmic Ca2+,measured using the cytoplas-
mic indicator GCaMP2 (Fig. 2A). However, we found that the rate of loss
of ATP, as measured using AT1.03, was more rapid in dendritic regions
than in the soma over early time points (Fig. 2B, C).
Loss of mitochondrial membrane potential (Ψm) is an early event in
excitotoxicity, initially triggered by mitochondrial Ca2+ uptake [1,82],
but later irreversible and Ca2+-independent, involving PARP-mediated
depletion of NADH [1]. We therefore decided to investigate whether
the mitochondria in these different regions respond differently to
excitotoxic Ca2+ inﬂux. Using the Ψm probe rhodamine-123 (Rh123),
we studied the loss of Ψm in response to bath application of NMDA.
Rh123 partitions into the polarised mitochondria of neurons where its
accumulation causes self-quenching. When the mitochondria
depolarise during exposure to excitotoxic insults, Rh123moves increas-
ingly into the cytoplasm, whereupon it de-quenches and its ﬂuorescent
signal increases [57,86]. The ﬂuorescence signal is normalised cell-to-
cell and region-to-region by calculating the maximal ﬂuorescence at
the end of the experiment upon completemitochondrial depolarisation
(achieved by FCCP treatment). We observed an initial slow modest
depolarisation in the soma of neurons, followed by a secondary, more
dramatic loss of Ψm (Fig. 2D, E). This has been described by others
and may involve cellular NADH loss and permeability transition [1]. In
dendritic regions however, while the initial slowmodest depolarisation
was also observed, the secondary loss ofΨmwas far less dramatic, and
in some cases missing entirely (Fig. 2D, E).
To investigate a potential reason for this, we measured Ca2+ uptake
into the mitochondria using matrix-targeted mito-GCaMP2, and found
no signiﬁcant differences between uptake in dendritic vs. somatic
regions (Fig. 2F). The fact that matrix Ca2+ rises to similar levels in the
somatic and dendritic mitochondria is consistent with the similar levels
of initial mitochondrial depolarisation, but begs the question as to why
secondary depolarisation is much stronger in somatic regions. Since
NADH depletion is an important mediator of the secondary component
of mitochondrial depolarisation [1], differences in NADH depletion offer
another explanation. We studied NAD(P)H autoﬂuorescence which,
since NADH is in excess over NADPH, primarily reports NADH levels.
As with previous studies, we observed that NADH autoﬂuorescence
was concentrated in the mitochondria throughout the neuron. We
found that the proportional drop in NADH in somatic regions was
Fig. 1. Dendritic regions are subject to greater ﬂuctuations in the GSH redox potential after exposure to sub-toxic H2O2. A) Example of a Grx1-roGFP2 expressing neuron, with the soma
(blue) and dendrite (red highlighted). Scale bar= 10 μm. B, C) Grx1-roGFP2 expressing neuronswere treated (DTT at 10mM) as indicated and the ﬂuorescence ratio (ex: 387± 5:494±
10, em: 530 ± 10) calculated, and normalised to the pre-treatment (Con) somatic ratio of that cell. *p b 0.05 two way ANOVA plus Bonferroni's post-hoc test (n= 9–23). #p b 0.05 com-
paring that condition to untreated (control) condition for that particular subcellular region (two way ANOVA plus Dunnett's post-hoc test (n= 9–23)). D, E) The change in Grx1-roGFP2
390/480 ratio induced by either DTT (D) or 10 μM H2O2 (E) is shown. *p b 0.05 Student t-test (n = 14 (D), n = 9 (E)).
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tential explanation for the more dramatic mitochondrial depolarisation
observed in the soma. Collectively, these data employing a range of im-
aging approaches reveal distinct differences in the response of the soma
and dendrites to relatively uniform levels of NMDAR-dependent Ca2+
inﬂux.2.3. Analysis of adaptive metabolic responses to network-wide action
potential burst activity
While Ca2+ inﬂux through the bath application of high concentra-
tions of NMDA triggers excitotoxic death, physiological patterns of
Ca2+ inﬂux, such as those triggered by synaptic activity or action
potential bursting, are well-tolerated and indeed can trigger long-
lasting neuroprotective adaptive responses [9]. Nevertheless, electrical
activity is energetically and metabolically demanding, particularly at
the synapses [50], and is known to trigger rapid adaptive responses to
meet this increased demand [44,50]. Against this context we wanted
to know whether burst activity triggered different responses in den-
drites vs. the somawith regard to energetic andmetabolic homeostasis.
Under basal conditions, ﬁring activity is relatively variable cell-to-cell,
with ‘events’ ranging from single action potentials (APs) to short bursts.
Activity can be enhanced by network disinhibition achieved by treat-
ment with the GABAA receptor antagonist bicuculline [48]. This results
in an increase in AP burst duration and frequency (Fig. 3A–C), while at
the same time rendering responses far more homogeneous cell-to-cell
(since the activity is synchronized across the network). In addition,
the average degree of depolarisation during each event is substantially
increased (Fig. 3D). In order to enhance the metabolic demands on the
cell still further, we co-treated neurons with bicuculline along withthe weak K+ channel blocker 4-aminopyridine (4-AP) [48], which en-
hances both burst frequency and duration (Fig. 3A–C), albeit with a
slight reduction in average intra-event depolarisation (Fig. 3D).
We observed clear evidence of increased metabolic activity to coun-
ter the increased energy demand of ﬁring activity triggered by
bicuculline/4-AP. Oxygen consumption rate (measured by a Seahorse
bioanalyzer) was elevated, indicative of increased oxidative phosphory-
lation (Fig. 3E, F). Moreover we observed activating dephosphorylation
(on serine 293) of pyruvate dehydrogenase (Fig. 3G), which increases
ﬂux through the TCA cycle [83] and may contribute with Aralar activa-
tion to boost oxidative phosphorylation. To determine whether this
resulted in increased NADH production, we employed the genetically
encoded indicator of cellular NADH:NAD ratio Peredox [51]. We used
the nuclear-targeted form of Peredox because (as previously reported)
expression of the cytoplasmic version results in lysosomal inclusions
in neurons [51]. We ﬁrst validated the probe in our hands using varying
ratios of lactate and pyruvate to alter the cellular NADH:NAD ratio
(Fig. 3H, I). We then studied the impact of BiC/4-AP treatment and
observed a strong increase in the Peredox-reported NADH:NAD ratio,
consistent with increased NADH production (Fig. 3J).2.4. Analysis of subcellular metabolic responses during action potential
burst activity
Since Peredox did not give any spatial information on NADH levels,
we had to resort to imagingNAD(P)Hautoﬂuorescence to study somatic
vs. dendritic responses. We observed increases in NADH autoﬂuores-
cence in both somatic and dendritic areas, suggestive of enhanced ﬂux
through the TCA cycle in both regions. However, the fold increase in
NADH levels was lower in dendritic regions than in somatic ones
Fig. 2.During excitotoxicity dendrites suffermore rapid ATP loss but lessmitochondrial dysfunction. A) Ca2+ imaging of neurons expressing Cyt–GCaMP2 before and after treatment with
NMDA.AverageCa2+ concentration over the 60 s post NMDA treatment in somata anddendrites is shown. *pb 0.05 paired t-test compared to pre-stimulation level (n=28). B, C)Neurons
expressing AT1.03 were treated with NMDA as indicated and the YFP:CFP FRET ratio was calculated (ex: 427 ± 5 nm; em: 427 ± 15: 542 ± 13). The change in FRET ratio post-NMDA
treatment is shown (value at t= 0minus value at t), with an increasing value indicating a decreasing FRET ratio (meaning a reduction in ATP). (B) shows example trace, (C) shows quan-
titation. *p b 0.05 twoway ANOVAplus Bonferroni's post-hoc test (n= 8). D, E) Neurons loadedwith rhodamine-123were treatedwith NMDA and ﬂuorescencemeasured in somatic and
dendritic regions, expressed as a percentage of themaximumobtained upon addition of FCCP. (D) shows a single experiment tracking 20 somatic and 20 dendritic regions (thin lines) and
their means (thick lines). (E) shows the maximum depolarisation within two time windows that correspond to primary (50–100 s post-NMDA) and secondary (250–350 s post-NMDA)
phases of somatic depolarisation. *p b 0.05 t-test (80 somatic and dendritic regions within n= 4 independent experiments). F) Ca2+ imaging of neurons expressing mito-GCaMP2 before
and after treatment with NMDA. Average Ca2+ concentration over the 60 s post-NMDA treatment in somata and dendrites is shown. #p b 0.05 paired t-test compared to pre-stimulation
level (n= 12). G, H) NAD(P)H autoﬂuorescence (ex: 387± 5, em: 447± 30) was measured before and after NMDA treatment. (G) shows an example of a single experiment tracking 10
somatic and 10 dendritic regions (thin lines) and their means (thick lines). (H) shows the % drop in NAD(P)H autoﬂuorescence (recorded until autoﬂuorescence plateaued at ~300 s post
NMDA). *p b 0.05 t-test (80 somatic and dendritic regions within n = 8 independent experiments).
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to be a driver of enhanced NADH production, we investigated whether
there were any differences in activity-dependent Ca2+ dynamics atsomatic vs. dendritic locations. Using cytoplasmic GCaMP2we observed
that Ca2+ elevation in somatic regions was on average higher than in
dendritic regions (Fig. 4C, D). In particular we observed that somatic
Fig. 3.Network disinhibition triggers strong AP bursting and increasedmetabolic activity. A) Examplewhole-cell current clamp recording of a neuron treated as indicatedwith bicuculline
(50 μM) ± 4-aminopyridine (250 μM). Regions marked in red in the upper picture are expanded in the lower pictures. Scale bars: 10 mV/10s (upper); 10 mV/50 ms (lower left); and
10 mV/1 s (lower middle and left). B–D) Effect of bicuculline (BiC) or BiC/4-AP (BiC4) on neuronal activity. The frequency of episodes of ﬁring activity (B), their duration (C) and the
average amount of intra-episode depolarisation (D) are shown. *p b 0.05 ANOVA plus Bonferroni's post-hoc test (n = 14). E, F) Example experiment showing an increase in oxygen con-
sumption rate (OCR) by BiC/4-AP treatment (BiC4). Subsequent treatment with oligomycin (1 μM) illustrates that OCR is driven primarily by mitochondrial ATP production. Treatment
with the uncoupler FCCP (0.125 μM) uncovers the maximal OCR rate, and the OCR after treatment with antimycin (2 μM) plus rotenone (2 μM) (Ant/Rot) represents non-mitochondrial
oxygen consumption. (F) shows quantitation of BiC/4-AP-induced OCR. *p b 0.05 t-test (n = 17). G) Western analysis of PDH dephosphorylation in response to BiC/4-AP-induced burst
activity. *p b 0.05 t-test (n=3). H) Example trace showing theﬂuorescence of Peredox (ex: 387±5, em: 530±10, normalised to itsmCherry tag ex: 575±12, em: 628±24) in neurons
exposed to different ratios of lactate:pyruvate, which alters the cellular NADH:NAD ratio. I) From the calibration data in (H), plus knowledge of the equilibrium constant k = 1.11 ∗ 10−4
of lactate dehydrogenase (to convert lactate:pyruvate to NADH:NAD), the relationship of Peredox ﬂuorescence to NADH:NAD is calculated. Seemethods for further details. J) Effect of BiC/
4-AP (BiC4)-induced burst activity on cellular NADH:NAD ratio. *p b 0.05 t-test (n = 19).
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they tended to fall down towards baseline levels (Fig. 4C). We have
reported these differences in Ca2+ dynamics previously in rat hippo-
campal neurons which we attributed to more efﬁcient Ca2+ clearance
from dendritic regions [48]. As a likely consequence of these differences
in cytoplasmic Ca2+ dynamics, levels of activity-dependent mitochon-
drial Ca2+ elevationwere also lower in dendritic regions than in somatic
regions (Fig. 4E, F). Finally we looked at ATP levels, to determinewhether the adaptive responses of somatic vs. dendritic regions differed
in their capacity to counter the energetic demands in their respective
subcellular locations. We found that ﬁring activity caused a depression
of cellular ATP levels, smaller than those observed in response to
excitotoxic insults but signiﬁcant nonetheless. Of note, we found that
the drop in ATP levels was more pronounced in dendritic regions than
in the soma (Fig. 4G, H), suggestive of a greater imbalance between
energy use and supply in dendrites during periods of intense activity.
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Here we have shown signiﬁcant differences in how dendrites and
soma respond to the same challenge, be it oxidative, excitotoxic or
activity-dependent. This adds to a body ofwork reporting selective den-
dritic responses to these types of insult, but raises the question as to
what the basis for these differences is.
3.1. Dendritic vs. somatic responses to ROS exposure
Oxidative stress occurs when there is an imbalance between the
level of ROS and a cell's ability to neutralise them utilising their intrinsic
antioxidant defences, while mild oxidative perturbations can trigger
adaptive protective responses [10,11,45,47]. Our study revealed that
exposure of cortical neurons to low levels of H2O2 triggered a greater
shift in the GSH redox potential in dendrites compared to the soma of
the same neuron. Several factors can inﬂuence how strongly the GSH
redox potential is perturbed, including the rate of production of GSH,
the reduction of oxidised GSSG back to GSH, and of course the oxidation
of GSH by GSH peroxidases to neutralise H2O2. The stronger perturba-
tion of the GSH:GSSG ratio in dendrites upon exposure to H2O2 could
conceivably be due to dendritic vs. somatic differences in one or all of
these factors. However, an additional consideration is the greater
surface area: volume ratio of dendrites compared to somata, resulting
in a higher amount of H2O2 ﬂux into the cytoplasm relative to the vol-
ume of cytoplasm available to reduce it. It will also be of interest to
know whether very prolonged exposure to H2O2 results in the GSH:
GSSG ratios in both compartments becoming more similar. Deregula-
tion of glutathione homeostasis and other antioxidant systems is impli-
cated in the aetiology of several neurodegenerative disorders associated
with dendritic pathologies, including: Alzheimer's disease, Huntington's
disease, ALS Friedreich's ataxia, and Parkinson's disease [8,54,65], and
activation of GSH pathway enzymes, particularly in astrocytes, is a po-
tential therapeutic strategy for combating oxidative stress in the brain
[39,41]. Moreover, deﬁcits in the GSH system have been implicated in
the pathophysiology of neuropsychiatric disorders, including schizo-
phrenia, bipolar disorder and autistic spectrum disorder [24,30,31,33,
38,43,59,69], associated with more subtle dendritic disturbances such
as spine alterations. One would expect that any perturbations to the
GSH system would disproportionately affect dendritic (and axonal)
regions upon exposure to ROS, either generated endogenously or
exogenously (e.g. by microglia).
3.2. Dendritic vs. somatic responses to excitotoxic Ca2+ inﬂux
The neurotoxicity of sustained glutamate exposure [64], later
termed excitotoxicity [78] is predominantly down to excessive Ca2+
inﬂux through the NMDAR [16,18,19], and can kill human neurons as
well as rodent ones [40]. Thework of many laboratories have contribut-
ed to our understanding of how glutamate dyshomeostasis, ionic imbal-
ance and abnormal NMDAR activity can contribute to excitotoxicity in a
variety of acute and chronic disorders [5,14,21,28,29,56,62,76].
Mechanisms of excitotoxicity can differ depending on the intensity
of insult [4,12], although other factors such as synaptic/extrasynaptic lo-
cation and subunit composition also matter [46,88,89]. Acute
excitotoxicity (as used in this current study) is associated with a rapid
drop of ATP, loss of mitochondrial membrane potential, and delayed
Ca2+ deregulation [1,26]. Collapse of the mitochondrial membrane po-
tential following NMDAR activation requires Ca2+ inﬂux and is
prevented by inhibitors of the potential driven mitochondrial Ca2+
uniporter [57], a channel whose molecular identity and accessory
factors have been recently uncovered [7,20,22]. However, events other
than mitochondrial Ca2+ uptake are required for mitochondrial mem-
brane potential collapse. Current models suggest that increased ROS
(especially superoxide) production induced by mitochondrial Ca2+ up-
take [26], and by cytoplasmically-activated ROS sources such as NADPHoxidase [13], combined with NO induced by nNOS activation leads to
peroxynitrite-induced DNA damage, resulting in PARP-1 activation
[26]. PARP-1 activation can then lead to the release of apoptotic factors
from the mitochondria [90] as well as cellular NAD depletion and/or in-
hibition of glycolysis [3], leading to collapse ofmitochondrialmembrane
potential due to a loss of the supply of reducing equivalents to the
electron transport chain [1]. Our observations regarding the subcellular
responses of somata vs. dendrites to excitotoxic insults suggest a
disconnection between the severity of ATP depletion and the degree
of mitochondrial depolarisation.
Following NMDA application, matrix Ca2+ levels rise equally in
somata and dendrites (Fig. 2), and the immediate modest loss of mito-
chondrial membrane potential (likely a direct consequence of positively
charged Ca2+ uptake), is also similar in both regions. However, while
mitochondrial depolarisation and NADH depletion is more modest in
dendritic regions, ATP loss is actually more rapid (Fig. 2). One possible
explanation for the reduced NADH depletion is that PARP-1 activity is
lower in dendritic regions, which is certainly a possibility since the cur-
rent dogma states that PARP-1 activation is triggered by DNAdamage in
the nucleus. This could then explain why mitochondrial depolarisation
is more modest in dendritic regions. However, it does not explain the
rapid loss of ATP observed in dendrites. One possibility is that ATP utili-
zation is much higher in dendritic regions, for example to maintain
cytoplasmic Ca2+ concentrations at healthy levels in the face of high
rates of Ca2+ inﬂux. It is easy to envisage that dendritic regions have a
higher ratio of NMDARs to cytoplasmic volume than somatic regions,
meaning a greater demand on ATP-utilising plasma membrane and ER
Ca2+ pumps. Regardless, it is clear that in both regions mitochondrial
depolarisation is not themain trigger for ATP loss, given that the former
occurs well after the latter. Accelerated ATP loss within dendrites may
be a consequence of unsustainable demands on the Na+/K+ ATPase in
dendrites due to Ca2+ and Na+ inﬂux [37]. This increased ion ﬂux also
contributes to morphological changes to dendrites, such as dendritic
beading [37,73] and spine loss [73].
3.3. Dendritic vs. somatic responses to ﬁring activity
Here we have shown that bicuculline method of network disinhibi-
tion is a good stimulation paradigmwithwhich to study energy use and
energy production during network activity. Bicuculline-induced ﬁring
activity results in increased oxygen consumption, indicative of in-
creased oxidative phosphorylation. This is likely to be mediated sub-
stantially by the cytoplasmic Ca2+-dependent activation of the Aralar
component of the malate–aspartate shuttle (MAS) which functions to
deliver reducing equivalents into the mitochondria (to reduce mito-
chondrial NAD+ toNADH) aswell as promoting generation of pyruvate
[32,63]. Additionally, increased ﬂux through the glycolytic pathway is
suggested by the fact that the cellular NADH:NAD ratio (as measured
by Peredox) increases sharply. Moreover, increased mitochondrial
NADH levels in response to burst activity are clearly visible in the
NADH autoﬂuorescence imaging experiments. This increase is poten-
tially due to both increased supply of electrons via the MAS, as well as
activation/dephosphorylation of pyruvate dehydrogenase (Fig. 3G)
and activation of Ca2+ dependent enzymeswithin the TCA cycle [27,34].
The energy cost of synaptic transmission and action potential ﬁring
is dealt with in excellent reviews elsewhere [50]. However, a key con-
clusion of previous studies is the very high energy cost associated
with glutamate receptor activation (and recovery therefrom), which
represents around 50% of all energy associated with synaptic transmis-
sion and AP ﬁring [44]. As such, dendrites are likely to be associated
with particularly strong ATP consumption during network activity, po-
tentially explaining the higher rate of ATP loss in this region, compared
to the soma (Fig. 4F, G). Of course though, theremay also be differences
in the ability of dendritic mitochondria to boost energy production,
compared to those at the soma, for example due to a more limited sub-
strate supply. The activity-dependent increase in NADH within
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at such a scenario. Alternatively, the temporal Ca2+ dynamics within
dendrites may be less efﬁcient at promoting the type of adaptive pro-
cesses described in the previous paragraph. During burst activity, both
cytoplasmic and mitochondrial Ca2+ levels are lower than at the soma
(Fig. 4C, E), at least in part due to more rapid clearance of Ca2+ from
the dendrites in between bursts (see Fig. 4B and [48]). As a result, the
Ca2+-dependent activation of Aralar or of matrix dehydrogenases
could potentially be weaker within dendrites.
4. Concluding remarks
The development of genetically encoded probes by a number of
laboratories for a variety of second messengers and metabolites is
enabling changes in these to be tracked with greater accuracy and
spatio-temporal resolution. The considerable differences in the re-
sponses of dendrites and soma to a variety of challenges described
in this study have been illuminated thanks to these newly devel-
oped probes as well as more established ones. Collectively they
point to dendrites being particularly vulnerable to both oxidative
stress aswell as energy deﬁcits. Sincemanyneurodegenerative diseases
and disease-causing agents are associated with excessive reactive spe-
cies production and metabolic/bioenergetic perturbations, this in-
creased vulnerability is potentially a contributing factor to early
dendritic changes in a variety of neurodegenerative diseases.
5. Methods
5.1. Cell culture
Cortical neurons were cultured from E17.5 CD1 mouse embryos,
essentially as previously described [2,81], at a density of between 9–
13 × 104 neurons per cm2. Cultures were prepared in Neurobasal
growth medium plus 1% rat serum (Harlan Laboratories), B27 (Life
Technologies Ltd), 1 mM glutamine and 1x antibiotic/antimycotic (Life
Technologies Ltd). To prevent excessive astrocyte proliferation in neu-
ronal cultures, the anti-mitotic drug cytosine β-D-arabino-furanoside
hydrochloride (1.2 mM) was applied on DIV4. Cultures were utilised
as indicated between DIV9–11, and were fed with the above described
appropriate growthmediumonDIV4. Prior to transfection cellswere re-
moved from growth medium and washed and placed in a minimal de-
ﬁned medium [79] containing 10% Minimum Essential Media (MEM,
Life Technologies Ltd) and 90% salt–glucose–glycine (SGG) medium
[6], which is comprised of 114 mM NaCl, 0.219% NaHCO3, 5.292 mM
KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM HEPES, 1 mM glycine, 30 mM
glucose, 0.5 mM sodium pyruvate, and 0.1% Phenol Red; osmolarity
325 mosm/l for at least 3 h.
5.2. General imaging parameters
Imaging was performed at 37 °C in ACSF (in mM): NaCl (150), KCl
(3), HEPES (10), glycine (0.1), CaCl2 (2), MgCl2 (1), and glucose (10),
pH 7.4 (this was used in all imaging experiments). Images were
captured using a DFC350 FX digital camera as part of a Leica AF6000
LX imaging system. Dendritic ROIs chosen were greater than 2 cell
bodies away from the soma and at least 5x narrower.Fig. 4. In response to AP bursting dendritic regions experience lower Ca2+ levels, exhibit wea
measured before and after BiC/4-AP (BiC4) treatment. (A) shows an example of a single expe
lines). (B) shows the fold increase in NAD(P)H autoﬂuorescence 10–16 min post-BiC/4-AP (BiC
ments). C–F) Ca2+ imaging of neurons expressing cyto-GCaMP2 (C, D) or mito-GCaMP2 (E, F)
Ca2+ levels within a single cell (dendrite vs. mitochondria). (D, left) and (F, left) show the ave
(D, right) and (F, right) show thedifferencebetween pre- and post-BiC/4-AP stimulation Ca2+ lev
GCaMP2 and n = 8 cyto-GCaMP2 cells). G, H) Neurons expressing AT1.03 were treated with B
treatment is shown (value at t = 0minus value at t), with an increasing value indicating a decr
quantitation. *p b 0.05 two way ANOVA plus Bonferroni's post-hoc test (n = 7).5.3. Peredox calibration, imaging and data analysis
Peredox is a genetically encoded, circularly permuted ﬂuorescent
reporter of the NADH/NAD+ ratio. The probe was excited at 387 ±
5 nm and 575 ± 12 nm and emission collected at 530 ± 20 nm and
628 ± 14 nm. Peredox can be calibrated by replacing the glucose in
the aCSF with lactate and/or pyruvate (both Sigma), which are the
products and substrates of the lactate dehydrogenase (LDH). Lactate
will cause LDH to produce NADH (hence increase Peredox ﬂuores-
cence), while adding pyruvate will have the opposite effect. Different
lactate:pyruvate ratios were applied to neurons transfected with
Peredox in order to obtain a relationship between the lactate:pyru-
vate ratio and the percentage of maximum Peredox ﬂuorescence,
with lactate alone set to 100%. Lactate:pyruvate ratios were convert-
ed into NADH/NAD+ levels by using the LDH equilibrium constant
(k), with k = (pyruvate ∗ NADH) / (lactate ∗ NAD+) and k =
1.11 ∗ 10−4. This allows to convert the % of maximum ﬂuorescence
(achieved by washing on lactate only) into NADH/NAD+ ratios. To cal-
ibrate single experiments, at the end of each recording, aCSF containing
lactate (10 mM) was applied to obtain the maximum ﬂuorescence of
Peredox and ﬂuorescence was converted into NADH/NAD+ ratios. All
measured valueswere normalised to the signal obtained frommCherry,
which is tagged to the Peredox protein. Images were taken every 20 s.
5.4. GCaMP2 Ca2+ imaging
Neurons were transfectedwith GCaMP2-encoding vectors (targeted
to various locations), the ﬂuorescence signal of which was detected
using a standard GFP ﬁlter set (ex 480 ± 20; em 527 ± 15). Changes
in Ca2+were expressed as (F− Fmin) / (Fmax− F) according to the equa-
tion [Ca2+] = Kd*(F− Fmin) / (Fmax−F). Fmax was obtained when cells
were treatedwith the cell-permeable Ca2+ ionophore ionomycinwhich
both inserts into the plasma membrane and passes into the cell,
inserting into mitochondrial membranes [75], leading to saturation of
the indicator when in regular medium (2mMCa2+). Fmin was obtained
under the same conditions except in zero Ca2+medium. The linear rela-
tionship between [Ca2+] and (F− Fmin) / (Fmax− F) has been previously
conﬁrmed by calibrating the indicator as expressed in neurons, expos-
ing them to ionomycin in the presence of sequentially different solu-
tions of precise [Ca2+], obtained by mixing K2EGTA and CaEGTA
solutions (Calcium Calibration Buffer Kit, Invitrogen) at different ratios
[82].
5.5. Mitochondrial membrane potential imaging, and data analysis
Mitochondrial membrane potential was analysed as described [49,
57] using Rh123 (Molecular Probes). Brieﬂy, neurons were loaded
with Rh123 (10 μg/ml or 26 μM) in SGG medium for 10 min followed
by extensive washing with SGG. Rh123 partitions into the polarised
mitochondria where it self-quenches at the concentration used. When
the mitochondria depolarise, Rh123 leaks out of the mitochondria into
the cytoplasm where it dequenches and ﬂuoresces strongly. Maximum
Rh123 signal (ex 480 ± 20; em 527 ± 15) was obtained by completely
eliminating themitochondrial potential by exposing the neurons to the
mitochondrial uncoupler FCCP (5 μM; Sigma). The NMDA-induced
change in Rh123 ﬂuorescencewasmonitored in a number of cell bodies,ker NADH production, and suffer higher ATP losses. A, B) NAD(P)H autoﬂuorescence was
riment tracking 20 somatic and 20 dendritic regions (thin lines) and their means (thick
4). *p b 0.05 t-test (160 somatic and dendritic regions within n = 8 independent experi-
before and after treatment with BiC/4-AP. (C) and (E) show example traces depicting the
rage Ca2+ concentration over the 60 s pre- and post-stimulation in somata and dendrites.
els. #p b 0.05 compared to pre-stimulation level; *pb 0.05 somavs. dendrite (n=12mito-
iC/4-AP as indicated and the YFP:CFP FRET ratio calculated. The change in FRET ratio post-
easing FRET ratio (meaning a reduction in ATP). (G) shows example trace, and (H) shows
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duced) signal within that region of interest. Background ﬂuorescence
(the signal obtained in an area devoid of cells) was subtracted from
images prior to any analysis.
5.6. NAD(P)H autoﬂuorescence imaging
To measure NAD(P)H autoﬂuorescence, cells were excited at 387 ±
5 nm and emitted light was collected at 447 ± 30 nm. Images were
acquired every 20 s. 10–20 somas and dendritic areas were selected
per recording. The drop in NAD(P)H autoﬂuorescence was recorded
until levels plateaued (~300 s post-NMDA). For experiments where
BiC/4-AP was applied to the cells, NAD(P)H autoﬂuorescence was mea-
sured for 10–16 min.
5.7. ATP (AT1.03) imaging and data analysis
AT1.03 is a YFP/CFP based FRET probe reporting ATP levels.
Transfected cells were excited at 427 ± 5 nm and CFP and YFP/FRET
emission was collected at 472 ± 15 nm and 542 ± 13 nm, respectively.
Images were acquired every 5 s. To calibrate AT1.03, the mitochondrial
uncoupler FCCP (10 μM) was applied, which deprives cells of ATP and
gives the minimum AT1.03 ﬂuorescence. After background subtraction,
the YFP/CFP ratio was calculated for each region of interest. The YFP/CFP
ratio obtained with FCCP was subtracted from the raw YFP/CFP ratio.
The drop in ATP following the application of NMDA or BiC/4-AP was
described as the change in the YFP/CFP ratio from the baseline.
5.8. GSH redox potential imaging (Grx1-roGFP2) and data analysis
Grx1-roGFP2 is a genetically encoded reporter of the glutathione
redox potential. It was excited at 387 ± 5 and 494 ± 10 nm and emis-
sion collected at 530 ± 10. Images were acquired every 20 s. The 387/
494 ratiowas calculated after background subtraction. In order to inves-
tigate perturbations of the redox potential, 10 μM H2O2 (Sigma) was
added to Grx1-roGFP2 transfected cells, which causes a non-saturating
increase in the 387/494 ratio (peak responses were calculated). In
order to calibrate the sensor, 100 μM H2O2 was applied to the cells, at
which Grx1-roGFP2 reaches saturation.
5.9. Electrophysiological recording and analysis
Coverslips containing cortical DIV9–10 neurons were transferred to
a recording chamber perfused (at a ﬂow rate of 3–5ml/min)with an ex-
ternal recording solution composed of (in mM): 150 NaCl, 2.8 KCl, 10
HEPES, 2 CaCl2, 1 MgCl2, 10 glucose, and 0.1 glycine, pH 7.3 (320–330
mOsm). Patch-pipettes were made from thick-walled borosilicate
glass (Harvard Apparatus, Kent, UK), with a tip resistance ranging be-
tween 4–8 MΩ, and ﬁlled with a K-gluconate-based internal solution
containing (in mM): K-gluconate 141, NaCl 2.5, HEPES 10, and EGTA
11; pH 7.3 with KOH. Recordings were at room temperature (21 ±
2 °C) using a Multiclamp 200B ampliﬁer (Molecular Devices, Union
City, CA). Both before and after current-clamp recordings, neurons
were voltage-clamped at−60 mV, and recordings were rejected if the
holding current was greater than−100 pA or if the series resistance
drifted by more than 20% of its initial value (b30 MΩ). Synaptic events
were ﬁltered at 5 kHz and digitized online at 20 kHz via a BNC-2090A/
PCI-6251 DAQ board interface (National Instruments, Austin, TX, USA)
and analysed usingWinEDR3.2 software (Dr JohnDempster, University
of Strathclyde, Glasgow, UK).
5.10. Transfection and plasmids
Neuronal transfections were carried out using Lipofectamine 2000
(2.33 μl/well, 1 μg/ml, Life Technologies Ltd) on DIV8 neurons. Plasmids
used have been previously described: pCAGGS–GCaMP2was a gift fromKarel Svoboda [67]; GCaMP2-mt was a gift from Xianhua Wang [15];
Grx1-roGFP2 was a gift from Tobias Dick [42]; and Peredox-NLS was a
gift from Gary Yellen [51].
5.11. Measurement of oxygen consumption rate
Oxygen consumption rate (OCR) was measured using the Seahorse
XF24 extracellular ﬂux analyser (Seahorse Bioscience). Cells were
plated on poly-D-lysine and laminin coated XF24 plates. One hour be-
fore the experiment, the medium was changed to XF assay medium
(modiﬁed DMEM),which does not include sodiumbicarbonate, supple-
mented with 10 mM glucose and pH adjusted to 7.4. The following
drugs were added sequentially: BiC/4-AP (50/250 μM), oligomycin
(1 μM), FCCP (0.125 μM) and antimycin A/rotenone (both 2 μM; except
for BiC/4-AP, all from Seahorse Bioscience). Oligomycinwill inhibit oxy-
gen consumption that is due to ATP production, while FCCP will uncou-
ple the mitochondria and thus increase mitochondrial respiration,
showing the cell's maximal respiratory capacity. After addition of
antimycin A and rotenone, which will fully inhibit mitochondrial respi-
ration, only non-mitochondrial oxygen consumption will be measured.
5.12. Western blotting
Gel electrophoresis and western blotting were performed using
the Xcell Surelock system (Invitrogen) using precast gradient gels
(4–20%) as described [68]. The following antibodies were used: Anti-
PDH-E1α (pSer293), Merck Millipore 1:10,000; and Anti-PDH-E1α,
Abcam, 1:10,000. For visualisation ofWestern blots, HRP-based second-
ary antibodies were used followed by chemiluminescent detection on
Kodak X-Omat ﬁlm. Western blots were analysed by digitally scanning
the blots, followed by densitometric analysis (ImageJ). For ﬁgure prep-
aration of example western blots, linear adjustment of brightness/con-
trast was applied (Photoshop) equally across the image.
5.13. Statistical analysis
Paired Student t-tests were used to compare non-independent data
pairs, while Student t-tests were utilisedwhen the two groupswere not
related. For studies employing multiple testing, we used a one-or two-
way ANOVA followed by Bonferroni's post-hoc test. In most cases den-
dritic and somatic responseswithin the same cell were being compared,
meaning that a repeated measure ANOVA was appropriate. For all tests
signiﬁcance was set at *p b 0.05. Error bars represent standard error of
the mean.
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